DatasetName,PSMA3_S(16) PSMA3_S(175) PSMA3_S(243) PSMA3_S(250) PSMA3_S(255) PSMA3_S(6),PSMA3_S(35) PSMA3_S(9)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.6049621039025578,0.4877220749593234
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.616325972880463,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6098721217210754,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5671875037209356,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.648247099554109,
DB2022_Intensity L2,0.6082655415032913,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.6113048594560131,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.5934806566235117,0.47848058672308325
RB2022_5_PreEndurance,0.614618613434092,0.4488972954934435
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6226996343254692,
WZ2023_Pu_010_30min,0.6361160533917665,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.6165754263355875,0.47667539896580846
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.6038963178239535,
KBE2022_Log2_Ex_14_U,0.6467350362755818,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6413627254404429,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.5727467437355106,
RB2022_5_PreSprint,0.6194568419565726,0.3093986664868519
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.5984820194373315,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5931208224623351,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.631974092897213,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5947864422231591,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.6079839463961608,0.4514093826858175
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.6055489045374758,
GF2025_P6_Sph,0.5834643567387757,
RB2022_2_PreSprint,0.6170460758296702,0.43731843165730955
ZX2022_CB treated Replicate 3,0.6084465255392256,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6385435404534946,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.6115124879214799,
KBE2022_Log2_Ex_34_U,0.6482415332605292,
WZ2023_Pu_005_10min,0.633290753601687,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6033890364995288,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.63350196773489,
AH2018_SILAC_MR_2_X,0.6031184974617524,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5923752039812417,0.5461766701404082
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5963575868905053,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5996356341419405,0.4752607904789051
EJN2021_3_Rest_Basal,0.6523541970596222,0.4969849261535878
CR2017_Ratio Replicate 1.3,0.5845730673594338,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6115257184010594,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6213217101585079,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6428885565736917,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6334542533889902,
CK2022_11 40-1,0.6040236017974006,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.6000665493287746,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.6324693366424872,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5859287561642976,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.6054149087594416,0.44272216167254086
DB2022_LFQ intensity L1.2,0.596043474763661,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6141383718665642,
CK2022_1 200-1,0.6357615266519335,
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,0.5726144329034225,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.6116867016527096,0.41096116000069693
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.589862684774531,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5907722482271215,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6090512094390337,
KBE2022_Log2_Ex_8_T,0.6486517076203734,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5681824492026478,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6085570011754068,
CK2022_3 40-1,0.6101641269614273,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.6564791079370292,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.5899542833140137,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.6285392892399403,
EJN2021_5_Rest_Basal,0.6451480396442051,0.5027474641073543
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6097247492539755,
YA2020_Reporter_intensity_Normal_No.1,0.6566093158114311,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.60883757556387,0.4599767316829261
RB2022_1_PostEndurance,,0.536768179828641
CR2017_Ratio Replicate 3,0.5724205098099854,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.5827987629925793,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5985622122771114,
HS2024_8_I_T3,,
CF2017_EOC 3,0.6115536071988308,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.636577097618444,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6108340832666278,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.6176601876991052,
KS2014_Intensity N3,0.6273956873745894,
RB2022_4_RecoveryEndurance,0.6176820341276987,
RB2022_5_RecoveryEndurance,0.6164140825571508,0.40657411240188485
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5870996069813614,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.6252567659494486,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5633506817219663,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6225009304134476,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6445600016106594,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5931285484402088,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.5265465592919524
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.6110925190585944,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6227402104563359,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6475601370302028,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.45855850644901675
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.6042330142053663,0.4021830140220202
AH2018_SILAC_IT_3_X,0.5863378167930551,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.5738757935804085,
CK2022_14 40-1,0.5975540561319473,
RB2022_6_PreSprint,0.6140312255941366,0.42004131672424483
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6028699507574226,
DL2023_control-1,,
AR2021_ALG 10 μM,0.582681532787752,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6130660099535828,
EJN2021_4_Rest_Ins,0.6476855447438447,0.5052357759427525
RN2012_H05,0.5751877261067816,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5814327936893243,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.6080897480423696,0.46714220357550196
EJN2021_1_Rest_Ins,0.6556283396396315,0.5030561623707421
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5893214997593791,
JW2021_After_3,0.6125431362611918,
GF2025_P8_Sph,0.5852476356082763,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.6290314253178073,
CK2022_12 200-1,0.6247829877756758,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.6318570002102702,
AH2018_TMTMS2_2_N,0.6416477320113035,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6478606904275535,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.44293313422558317
AH2018_TMTMS3_Pool,0.6217737692248123,
KS2014_Intensity N4,0.6328364871347869,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.5834424520923681,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.6289412266675919,
CK2022_14 200-1,0.6288038499240977,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.6015940513133724,0.46027317597611794
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.60299710411281,
AST2020_anti-CD3+PDL2.2,0.6123711452529061,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,0.6081303206347256,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.6209148555590113,0.5065654529623782
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.6004779905233254,
GF2025_P1_Adh,0.6092404144733209,
GF2025_P1_Sph,0.5748629613647441,
EJN2021_5_Ex_Basal,0.646667650111093,0.5033137789516107
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6342059870136113,
CF2017_EOC 1,0.6346110019253273,
CK2022_3 200-1,0.6357607640945969,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.590055849663746,0.508760763955578
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.6006189924146473,0.4708560553907968
CK2022_2 40-1,0.6086393870124727,
RB2022_1_PostSprint,0.6029558665199808,0.39574694619172673
CK2022_4 200-1,0.6344416896450434,
JW2021_Before_2,0.5969032236511178,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6149997370236268,
AR2021_ALG 1 μM,0.5568230770295526,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.6533211493473253,0.5117358772139287
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5774123942704588,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.6001878685848615,
CK2022_9 16-1,0.6040395277092553,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.6284913804951525,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,0.5994681631312918,
FS2019_db/db3,,
CK2022_15 40-1,0.5969515053158874,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6329738335337357,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.6500548841177877,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6342554785956339,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.6476640282041201,
AH2018_LFQ_M_1_N,0.595450019558513,
KBE2022_Log2_Ex_27_U,0.6468181348481542,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6336448287669233,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.60351552106553,0.4206112644566361
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.6135141196781583,0.4316363470652035
YA2020_Reporter_intensity_Normal_No.4,0.660989949285868,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5516640871237583,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.595327969044324,
RN2012_L13,0.602944573348143,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6497797484511072,
SR2019_SKBR3_Biol_repl_3,0.5832503657387048,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6083972401899844,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5909777870600578,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,0.6114975224041687,0.4452197657492636
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5799584961593429,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6487683135452423,
GF2025_P3_Adh,0.5933360010963483,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6406201862382729,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5678671794740626,
KBE2022_Log2_Ex_19_U,0.6467154871238933,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.6087045419084295,0.42208636993536586
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.660989949285868,
AST2020_Control,0.6101738419421407,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.590936306368749,0.4369342153877702
RB2022_7_RecoverySprint,0.601653336438945,0.49360733375062604
YA2020_Reporter_intensity_Normal_No.3,0.6566201437159512,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6319731806705546,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.660989949285868,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5710480655076052,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.6111528124593676,0.4535322664433451
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.6162230344968894,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6501298573081326,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6168633715399497,
KBE2022_Log2_Ex_9_U,0.6433521163837536,
AH2018_SILAC_M_3_N,0.6223632743862871,
KBE2022_Log2_Ex_13_T,0.6471930224326422,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,0.6180178706002105,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5781796047724677,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6076171512951077,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6121626391936937,
RB2022_7_RecoveryEndurance,0.6073797446028645,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.6505824768564039,0.5004057074511487
TM2022_S2.12h.B,,
RN2012_L15,0.5912838471797387,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5427745042790848,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6523474579059803,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.595224900394452,
RB2022_1_PreSprint,0.6164888410547794,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6361613236773511,
CK2022_5 200-1,0.6349410380928219,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.590041558334205,0.47774692185094225
AH2018_LFQ_2_C,0.6054087211352795,
AH2018_SILAC_MR_1_X,0.6000172881287823,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6511185819501842,
AH2018_SILAC_3_C,0.6076103886434554,
EJN2021_5_Rest_Ins,0.6453729227702292,0.4985931326060806
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,0.5876350378609191,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.6143827847178706,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.6251935932428531,0.5101534315571935
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5922588461810989,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.610499189481642,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6461634118882732,
AH2018_SILAC_IT_2_N,0.6149702051342217,
AH2018_SILAC_IT_1_X,0.5861572595355851,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.6337132406539535,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5525977185313884,
WZ2023_Pe_025_20min,0.6388018527284164,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.6499079835328946,
RN2012_H06,0.5858874894593139,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6286014716186711,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.6322606383224391,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6106364654656239,
WZ2023_Su_025_10min,0.6366532417495048,
AH2018_LFQ_IT_4_X,0.6115114787646968,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.5337880360457694
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6331852517690452,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.6158717173578383,0.3756913694190672
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5933310281680568,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.6056067972322191,0.514479181460821
KS2014_Intensity,0.6125550067137513,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.5950166562969158,
EP2017_Untreated R#1 normalized log2 ratio,0.584227476086096,
RN2012_L10,0.5773687148571115,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5881967877221947,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,0.5826245335040893,
KBE2022_Log2_Ex_24_T,0.650040762975303,
RB2022_8_PostStrength,0.6007850234625228,
AH2018_SILAC_IT_2_X,0.586247484056979,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6481218878458858,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.627145442511013,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5938684552297023,
GF2025_P9_Sph,0.5780087345667161,
CK2022_6 200-1,0.6358649616325608,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6067087482676815,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,0.5861276236830794,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.5783432328038742,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.6235993626614033,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6361621178541061,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5902717735312454,
RB2022_7_PostEndurance,0.596661600956745,0.4890389815743478
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5724591281536627,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6468625399998108,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.6251634920459622,0.5080589412195627
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.6172649095632184,0.48850688678018483
AH2018_SILAC_MR_3_N,0.6062643474619978,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.6497140176858972,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6459587030864388,
EP2017_Untreated R#3 log2 ratio,0.6236050757421964,
RB2022_2_PostStrength,0.6120268106332656,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5849151598624048,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.622895620724245,0.42815195752426016
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.643376804717048,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.62636028923776,0.40940487431742745
CR2017_Ratio Replicate 2.3,0.5758481209285594,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5474498783002647,
YA2020_Reporter_intensity_Normal_No.2,0.660989949285868,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5970912008180735,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6476702337548305,
CK2022_2 16-1,0.6137044430352468,
RAM2015_Log2 B,0.5922971873789348,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.6509530602305977,0.5099691371978493
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.6308211450852564,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.6374673746201663,
AH2018_LFQ_4_N,0.6030435040282875,
CR2017_Ratio Replicate 1.2,0.5943292041881093,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5986311431570652,0.4604610739342569
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.6329361626436941,
RB2022_7_PreEndurance,0.5974916742970134,0.311966545161714
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5812826992731767,
DB2022_LFQ intensity R2,0.597514568642052,
GF2025_P6_Adh,0.584653788102517,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.6060550887917104,0.434769459717282
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.6155111435294024,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.6128502409139537,0.44371803443267865
KS2014_Intensity C5,0.5887891470099836,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.621857230480266,0.40943486683764074
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5920991361017255,
RB2022_3_PostStrength,0.607332986738107,0.44006169047945665
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.6064257769614759,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.6056890465040917,
PG2020_Intensity 2h_B,0.5818378711864608,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.583586795353177,0.44903898629329786
KS2014_Intensity E15_3,,
GF2025_P3_Sph,0.5751570165275698,
DB2022_LFQ intensity L2,0.5964972359123578,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4900092467771738
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.611196213046097,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6134060850449319,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5830697622031767,
ZQ2022_N1,0.5817217021830566,
LY2019_P6-,0.5748640533415309,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.6307049141357429,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5583912446876533,
AH2018_LFQ_3_N,0.6008353170591517,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.6337155106320699,
KBE2022_Log2_Ex_13_U,0.6486528353113716,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.585895924280333,0.5063156204591802
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.6114422261955842,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5628366813495119,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,0.5957138629941469,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.597126034931661,0.5138860652570949
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6347413256135068,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5749781990043978,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5980637003876258,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5613857510332946,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.6105099986438595,0.29884344669856966
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.6504289301649643,0.4946151304377061
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.6268025378225874,0.513235169422236
EP2017_Pervanadate R#3 log2 ratio,0.5932698129159074,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.6029394811757042,
AH2018_SILAC_MR_3_C,0.5955979373265751,
AH2018_LFQ_M_4_C,0.6064715281657876,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,0.590016568476769,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5666682639933256,
CK2022_6 40-1,0.6122520873758505,
DB2022_LFQ intensity R2.1,0.5962802002992666,
KBE2022_Log2_Ex_42_U,0.6475436667258482,
LY2019_P3-,0.5934485164824643,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.6233456250365771,0.5102791599349893
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6371863373239327,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.6192895430252477,0.5069830152016006
AST2020_Control.1,0.6111284707997071,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6343827422710951,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5522423355500975,
RB2022_1_RecoveryStrength,0.6142663627625891,0.36205833808223986
SR2019_HCC1954_Biol_repl_4,0.5667297898225879,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6440518914624448,
RB2022_4_PreSprint,0.618581488111985,
DB2022_Intensity R2,0.6074462577779213,
AH2018_TMTMS2_Pool,0.6227395285260544,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.607472601379433,0.4453588358353581
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.632551235112599,
LY2019_P8+,0.5741703530778658,
RB2022_2_RecoveryEndurance,0.616642146324578,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.593859373120828,0.5134235437222597
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.45345712817809314
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5971785983673601,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6434348103577925,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.6397586378988398,
LY2019_P2-,0.574137851374567,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.6099710000941181,0.5187802372924527
WZ2023_Pe_005_20min,0.6349616170172782,
AST2020_Control.2,0.6106226710277788,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6093477276644709,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.6318280242340244,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.651224376329155,
AH2018_TMTMS3_3_N,0.6385301146014389,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6010619115500085,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5891574950347453,
KBE2022_Log2_Ex_36_T,0.6501575285292603,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6300965738936601,
KS2014_Intensity C2,0.5645980844400843,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6467292546576481,
CK2022_9 200-1,0.6293576316154942,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,0.5857752653454015,
CK2022_10 200-1,0.6334447879083293,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5804815838869383,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5836417211269012,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,0.5762746848965911,
EJN2021_3_Rest_Ins,0.654032551461314,0.5070423743020173
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6439934890829665,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5842294709130195,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6330226555212587,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6100815893213146,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5134803945123096,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5871738900902242,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5502896507584827,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6038175895675145,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5562444039878031,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5885621721261168,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.6101917509900207,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.610065265215081,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.636098344242419,
KBE2022_Log2_Ex_29_U,0.6461612432188951,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6107707068244721,
AH2018_LFQ_IT_4_N,0.6096829661874857,
CK2022_15 200-1,0.6280279631700393,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.6460228725084742,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5806239864110887,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6344408281823292,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6359260902633311,
RN2012_H01,0.5945184460018439,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.6236864702566841,0.5117822086967262
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5945960082468517,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.660989949285868,
KBE2022_Log2_Ex_44_U,0.6467026590551579,
WZ2023_Pe_010_20min,0.6352171411995294,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.6038249956371279,0.4326713379168243
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),0.612388439286212,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5914797791646899,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.6221743638261679,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.6207385686321377,
AH2018_SILAC_M_2_X,0.6209002736532215,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6493949597611851,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6335391272950502,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.605864134253726,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.645191339702757,
CK2022_15 16-1,0.6002130784730532,
CK2022_3 16-1,0.6140433620786049,
LY2019_P4-,0.5711560765032708,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.600599812132006,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.6056061311328913,
CK2022_10 16-1,0.6072590906436957,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,0.6085120361159756,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.6325438264744675,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,0.5897286765632549,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5937113865490059,
EJN2021_2_Ex_Basal,0.6191904095168965,0.5044263053800755
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.6440250711669261,
AR2021_L41 10 μM,0.5761973138755251,
CF2017_EOC 2,0.6267554482490864,
RB2022_6_PostEndurance,0.6090914579424535,0.44334500723483905
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.6332147322688826,
RB2022_7_PreSprint,0.6302576394130125,0.4197600103098612
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.6168404496966131,
ZX2022_CB treated Replicate 1,0.608484734049009,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.6203807491036639,0.4286231501382679
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6411218779431932,
AR2021_L41 1 μM,0.5452523616108014,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6406451168440277,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6090827998241047,
KS2014_Intensity C4,0.617255521166784,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6420078026046052,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6013004429617971,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.6566226801564203,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.6245714580787495,0.4032203012211569
AH2018_SILAC_IT_3_C,0.589299543894848,
WZ2023_Pu_025_10min,0.6357662711575517,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.6483593202466575,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.634264219691219,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5954162787277387,
ZQ2022_N3,0.5894010450907606,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5976351186558767,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.6104312193600155,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5961516420578373,
AH2018_SILAC_IT_2_C,0.5892881903471505,
CK2022_5 40-1,0.6087571327987163,
AH2018_LFQ_3_X,0.6002733309374301,
UK2020_UA_3,0.6339983892285644,
LY2019_P7-,0.5920861611843999,
GF2025_P5_Adh,0.5640851358827917,
RB2022_1_PostStrength,0.6022455102657657,0.39225917833451884
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.5694200523752276,
CR2017_Ratio Replicate 2.2,0.5814374966655443,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6039533712598484,
ZQ2022_C1,0.5887162368663221,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,0.5686015347036973,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6071472816579012,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.5848496082698502,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.6131857215740105,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5957239618476976,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6038229773899676,
YA2020_Reporter_intensity_Cancer_No.4,0.6565113237503186,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5879049018633453,
RB2022_2_PreEndurance,0.6057180669820942,
JW2021_Before_1,0.5874351418361371,
KBE2022_Log2_Ex_25_T,0.6474384316964273,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.6036944236917517,
AST2020_anti-CD3+PDL2,0.6112246790225881,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6424808097828056,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.6118097360498798,0.404546589778304
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.607591152371874,
EP2017_Mitotic R#2 log2 ratio,0.5898795589893612,
AH2018_TMTMS2_1_X,0.6416332366159335,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.6474181455251465,0.4986283844690005
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.637588528175033,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.6090405134108612,
CF2017_FTE 14,0.6360923473197267,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.649803751487084,
EP2017_Untreated R#2 normalized log2 ratio,0.5710844393416183,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,0.5886323675677226,
LY2019_P5+,0.5805377331741027,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5712617890389755,
AS2011_Ratio H/L Normalized RNAi_2_1,,
